Muscarinic agonists and antagonists in the treatment of Alzheimer's disease.
暂无分享,去创建一个
C. Strader | J. Lachowicz | J. Clader | K. Cox | S. Li | T. Asberom | G. Zhou | K Cox | W Billard | V Ruperto | W Greenlee | J Clader | T Asberom | S McCombie | J Ford | H Guzik | J Kozlowski | S Li | C Liu | D Lowe | S Vice | H Zhao | G Zhou | H Binch | R Crosby | R Duffy | J Lachowicz | V Coffin | R Watkins | C Strader | L Taylor | R. Watkins | V. Coffin | J. Kozlowski | S. Vice | R. Duffy | D. Lowe | H. Zhao | S. McCombie | W. Billard | H. Binch | V. Ruperto | H. Guzik | L. Taylor | J. Ford | W. Greenlee | C. Liu | R. Crosby
[1] C. Strader,et al. SCH 57790: a novel M2 receptor selective antagonist. , 1999, Life sciences.
[2] A. Fisher. Muscarinic Receptor Agonists in Alzheimer’s Disease , 1999 .
[3] E. Giacobini. Cholinergic foundations of Alzheimer's disease therapy , 1998, Journal of Physiology-Paris.
[4] Clader Jw. Recent advances in cholinergic drugs for Alzheimer's disease. , 1999 .
[5] W. Greenlee,et al. Metabolic stabilization of benzylidene ketal M(2) muscarinic receptor antagonists via halonaphthoic acid substitution. , 2001, Bioorganic & medicinal chemistry letters.
[6] H. Doods. Lipophilic muscarinic M2 antagonists as potential drugs for cognitive disorders , 1995 .
[7] M. Kistler,et al. Cholinergic improvement of a naturally-occurring memory deficit in the young rat , 1996, Brain Research.
[8] W. Greenlee,et al. Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists. , 2000, Bioorganic & medicinal chemistry letters.